Can drospirenone‑ethinyl estradiol cause mood swings?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Drospirenone-Ethinyl Estradiol Cause Mood Swings?

Drospirenone-ethinyl estradiol does not reliably cause mood swings or mood changes according to current evidence. In fact, this formulation is FDA-approved specifically for treating premenstrual dysphoric disorder (PMDD), which includes mood symptoms like depression, anxiety, and irritability 1.

Evidence Against Mood Swings as a Side Effect

The most authoritative pediatric guideline explicitly states that "neither weight gain nor mood changes have been reliably linked to use of combined hormonal contraception" 2. This represents the consensus position from the American Academy of Pediatrics based on comprehensive literature review.

Therapeutic Benefits for Mood

Paradoxically, drospirenone-ethinyl estradiol is indicated for treating mood-related symptoms:

  • FDA-approved for PMDD treatment, specifically targeting markedly depressed mood, anxiety, tension, affective lability, and persistent anger or irritability 1
  • Clinical studies demonstrate improvements in emotional symptoms including fatigue, depressive mood, anxiety/fears, and cognitive difficulties 3, 4, 5
  • The 24/4 regimen (24 active pills, 4 placebo) shows particular efficacy for emotional and physical symptoms of PMDD 4, 5

Important Clinical Nuances

One randomized controlled trial showed no benefit when drospirenone-ethinyl estradiol was used to augment antidepressants in women with premenstrual breakthrough depression 6. However, this studied a specific population already on antidepressants with established depressive disorders—not the general contraceptive-using population.

Common Pitfalls to Avoid

  • Don't confuse PMDD treatment with causing mood symptoms: This medication treats mood disorders; it doesn't cause them
  • Distinguish between transient adjustment symptoms and persistent mood changes: Early cycle irregular bleeding, headache, and nausea are common transient effects 2, but mood changes are not
  • Consider patient attribution bias: Women may attribute normal mood fluctuations to their contraceptive when no causal relationship exists

Bottom Line for Clinical Practice

If a patient reports mood swings on drospirenone-ethinyl estradiol, investigate alternative causes rather than automatically attributing symptoms to the medication. The evidence does not support mood changes as a reliable side effect of this formulation 2.

Related Questions

What are the active and inactive ingredients in Zamine (drospirenone/ethinyl estradiol) oral contraceptive?
What should I know about using Trisprintec (drospirenone/ethinyl estradiol) for birth control?
Does drospirenone (including drospirenone/ethinyl estradiol combination oral contraceptives) interact with lamotrigine?
Can a perimenopausal woman take Zamine (drospirenone 3 mg/ethinyl estradiol 20 µg)?
Can you provide a SOAP note for a 24-year-old female presenting for an annual well‑woman exam who wants birth‑control counseling, has a negative urine pregnancy test, no medications, no past medical history, is 6 months postpartum, reports hair shedding and fatigue, normal menstrual cycles, and was prescribed Yasmin (drospirenone/ethinyl estradiol) 3 mg daily, including appropriate CPT and ICD‑10 codes?
What are the appropriate management recommendations for a patient with normal‑sized left ventricle, mildly increased wall thickness consistent with concentric hypertrophy, preserved ejection fraction, reduced global longitudinal strain, grade I diastolic dysfunction, trace mitral and tricuspid regurgitation, and a trivial pericardial effusion?
After a pharmacologic nuclear stress test, if a patient is told their urine will remain radioactive for three days, what additional precautions, if any, are required?
How should abdominal bloating be evaluated and managed?
Can higher doses of sertraline cause abdominal pain in an adult without hepatic impairment, pregnancy, or severe gastrointestinal disease?
What comparable medications are alternatives to drospirenone‑ethinyl estradiol for contraception or premenstrual dysphoric disorder treatment?
What is the appropriate conversion of insulin glargine (Lantus) 30 U twice daily to insulin degludec (Tresiba)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.